Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – Chemical aftertreatment – e.g. – acylation – methylation – etc.
Patent
1993-11-15
1996-06-11
Chan, Christina Y.
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
Chemical aftertreatment, e.g., acylation, methylation, etc.
530408, 562875, 436 89, C07K 100, C07K 1107, C07K 1113, G01N 3348
Patent
active
055257070
DESCRIPTION:
BRIEF SUMMARY
FIELD OF THE INVENTION
This invention relates to the sequential degradation of proteins and peptides from the N-terminus. More particularly, the invention relates to the sequential N-terminal degradation of peptides, including small peptide samples utilizing a novel reagent which facilitates identification of the released amino acids by mass spectrometry or fluorescence.
BACKGROUND OF THE INVENTION
Proteins are linear chains of twenty covalently linked naturally occurring amino acids. The amino acid sequence or primary structure determines the manner in which the chain can fold to form the secondary and tertiary structures necessary for biological function. When only smaller quantities of a rare protein are isolated sequence analysis is an essential prerequisite to cloning.
Currently, protein sequence analysis is primarily accomplished with the use of an automated sequencer using chemistry developed by Edman over 40 years ago (Edman, Acta Chem. Scand. 4:283-293 (1950)). Since that time improvement in the instrumentation has resulted in the ability to sequence smaller and smaller sample quantities (mmole to pmol), although the original chemistry has remained essentially unchanged. Current automated instrumentation permits 10-20 cycles of sequence determination on 10-50 pmol of sample (Simpson, et al., Anal. Biochem. 177:221-236 (1989)).
Advances in protein isolation methodology have recently made it possible to isolate sub-picomole quantities of proteins of biological interest which are present in tissues. Improved methods of protein sequencing requiring less sample quantity would make it possible to obtain the necessary sequence information in order to clone and express these proteins, and hence to study the structure function aspects thereof. These proteins often have key roles in the development and treatment of human disease.
The major limitation of Edman chemistry is the practical detection limit of the peptidylthiohydantoin (PTH) amino acids. The current method involves separation of the PTH amino acids by high-performance liquid chromatograph (HPLC) using UV detection. The practical detection limit of this method is approximately 1 pmol. A number of methods have been proposed to increase the sensitivity of Edman degradation by the use of radiolabeled, chromophoric, or fluorescent isothiocyanate reagents. 4-(N,N'-Dimethylamino)azobenzene-4'-isothiocyanate (DABITC), a highly chromophoric reagent, was introduced by Chang (Chang, et al., Biochem. J. 153:607-611 (1976)). Fluorescent reagents, such as fluorescein isothiocyanate (Maeda, et al. Biochem. Biophys. Res. Commun. 31:188-192 (1968); Muramoto, K., et al. Anal. Biochem. 141:446-450 (1984)), and dansyl-containing isothiocyanates (Hirano, et al. Biol. Chem. Hoppe-Seyler 164:257-263 (1986); Hirano, et al. "Methods in Protein Sequence Analysis" (Ed. B. Wittman-Liebold) Springer-Verlag, Berlin, pp. 42-51 (1986); Jin, S. W., et al. FEBS Lett. 198:105-154 (1986); Jin, S. W., et al., In: Methods in Protein Sequence Analysis (Ed. B. Wittman-Liebold) Springer-Verlag, Berlin, pp. 34-41 (1989); Sainikow, J., et al. In: Methods in Protein Sequence Analysis (Ed. K. A. Walsh) Humana Press, Clifton, N.J., pp. 247-260 (1987)) have also been evaluated as sensitivity enhancing reagents. Although synthetically prepared amino acid analogues prepared using these reagents have shown subpicomole sensitivity by HPLC analysis, in automated sequencing the sensitivity of the standard Edman methodology has not been surpassed. It is postulated that the large chromophore of such reagents may interfere with the derivatization and cleavage reactions of the Edman degradation. The use of radiolabeled reagents has failed consequent from autoradiodegradation which results in decreasing product yields and increasing amounts of labeled by-products.
An alternative method has more recently been proposed which involves treatment of the anilinothiazolinone (ATZ) derivative normally formed in Edman chemistry with a fluorescent amine (Tsugita, A., et al., J.Biochem. 106:60-65 (1989)). The
REFERENCES:
patent: 5270213 (1993-12-01), Farnsworth
Streitwieser et al Introduction to Organic Chemistry pp. 157-183 1985.
Bailey Jerome M.
Shively John E.
Chan Christina Y.
City of Hope
Degen Nancy J.
LandOfFree
N-terminal peptide degradation utilizing dialkylthiocarbamoylhal does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-terminal peptide degradation utilizing dialkylthiocarbamoylhal, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-terminal peptide degradation utilizing dialkylthiocarbamoylhal will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-352539